The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-20 of 30 articles
Preprocedural physiological assessment of coronary disease patterns to predict haemodynamic outcomes post-PCI
Kotoku N,
Ninomiya K,
Masuda S,
O’Leary N,
Garg S,
Naito M,
Miyashita K,
Tobe A,
Kageyama S,
Tsai TY,
Revaiah PC,
Tu S,
Kozuma K,
Kawashima H,
Ishibashi Y,
Nakazawa G,
Takahashi K,
Okamura T,
Miyazaki Y,
Tateishi H,
Nakamura M,
Kogame N,
Asano T,
Nakatani S,
Morino Y,
Ishida M,
Katagiri Y,
Ono M,
Hara H,
Sotomi Y,
Tanabe K,
Ozaki Y,
Muramatsu T,
Dijkstra J,
Onuma Y,
Serruys P
November 14, 2023 | 10.4244/EIJ-D-23-00516
Online three-dimensional OFDI-guided versus angiography-guided PCI in bifurcation lesions: design and rationale of the randomised OPTIMUM trial
Miyazaki Y,
Muramatsu T,
Asano T,
Katagiri Y,
Sotomi Y,
Nakatani S,
Takahashi K,
Kogame N,
Higuchi Y,
Ishikawa M,
Kyono H,
Yano M,
Ozaki Y,
Serruys P,
Okamura T,
Onuma Y
March 19, 2021 | 10.4244/EIJ-D-18-00902
Neointimal hyperplasia of ultra-thin stents with microcrystalline sirolimus or durable polymer everolimus-eluting stents: 6- and 24-month results of the DESSOLVE III OCT study
Milewski K,
Takahashi K,
Asano T,
Katagiri Y,
Hochul M,
Buszman P,
Tomaniak M,
Gorycki B,
Zurakowski A,
Janas A,
Mlodziankowski A,
Kachel M,
Wykrzykowska JJ,
Wijns W,
de Winter R,
Buszman P,
Onuma Y,
Serruys P
February 19, 2021 | 10.4244/EIJ-D-18-01201
Treatment with a dedicated bifurcation sirolimus-eluting cobalt-chromium stent for distal left main coronary artery disease: rationale and design of the POLBOS LM study
Asano T,
Kogame N,
Onuma Y,
Modolo R,
Chichareon P,
Lefèvre T,
Legutko J,
Digne F,
Morel M,
Serruys P,
Gil R
October 23, 2020 | 10.4244/EIJ-D-19-00361
Preclinical evaluation of a thin-strut bioresorbable scaffold (ArterioSorb): acute-phase invasive imaging assessment and hemodynamic implication.
Katagiri Y,
Torii R,
Takahashi K,
Tenekecioglu E,
Asano T,
Chichareon P,
Tomaniak M,
Piek J,
Wykrzykowska JJ,
Bullett N,
Ahmed N,
Al-Lamee R,
Leclerc G,
Kitslaar P,
Dijkstra J,
Reiber J,
Poon E,
Bourantas C,
Gijsen F,
Serruys P,
Onuma Y
June 12, 2020 | 10.4244/EIJ-D-18-01190
Clinical outcomes of bioabsorbable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents: two-year follow-up of the DESSOLVE III trial
Katagiri Y,
Onuma Y,
Lurz P,
Buszman P,
Piek J,
Wykrzykowska JJ,
Asano T,
Kogame N,
Takahashi K,
Chang C,
de Winter R,
Serruys P,
Wijns W
February 7, 2020 | 10.4244/EIJ-D-18-00944
Acute and long-term relocation of minimal lumen area after bioresorbable scaffold or metallic stent implantation
Katagiri Y,
Serruys P,
Tenekecioglu E,
Asano T,
Collet C,
Miyazaki Y,
Katsikis A,
Piek J,
Wykrzykowska JJ,
Chevalier B,
Mintz GS,
Stone G,
Onuma Y
September 20, 2019 | 10.4244/EIJ-D-18-00422
Validation of the updated logistic clinical SYNTAX score for all-cause mortality in the GLOBAL LEADERS trial
Chichareon P,
Onuma Y,
van Klaveren D,
Modolo R,
Kogame N,
Takahashi K,
Chang C,
Tomaniak M,
Asano T,
Katagiri Y,
van Geuns R,
Bolognese L,
Tumscitz C,
Vrolix M,
Petrov I,
Garg S,
Naber CK,
Sabaté M,
Iqbal J,
Wykrzykowska JJ,
Piek J,
Spitzer E,
Jüni P,
Hamm C,
Steg G,
Valgimigli M,
Vranckx P,
Windecker S,
Serruys P
August 9, 2019 | 10.4244/EIJ-D-19-00184
A prospective multicentre randomised all-comers trial to assess the safety and effectiveness of the thin-strut sirolimus-eluting coronary stent SUPRAFLEX: rationale and design of the Thin Strut Sirolimus-eluting Stent in All Comers Population vs Everolimus-eluting Stent (TALENT) trial
Modolo R,
Chichareon P,
Kogame N,
Asano T,
Chang C,
de Winter R,
Kaul U,
Zaman A,
Spitzer E,
Takahashi K,
Katagiri Y,
Soliman O,
Van Es G-A,
Morel M,
Onuma Y,
Serruys P
July 19, 2019 | 10.4244/EIJ-D-18-00499
Early strut protrusion and late neointima thickness in the Absorb bioresorbable scaffold: a serial wall shear stress analysis up to five years
Tenekecioglu E,
Torii R,
Katagiri Y,
Asano T,
Modolo R,
Miyazaki Y,
Chichareon P,
Poon E,
Gijsen F,
Thondapu V,
van Klaveren D,
Jonker H,
Ooi A,
Barlis P,
Collet C,
Onuma Y,
Bourantas C,
Serruys P
July 19, 2019 | 10.4244/EIJ-D-18-00381
A randomised comparison of healing response between the BuMA Supreme stent and the XIENCE stent at one-month and two-month follow-up: PIONEER-II OCT randomised controlled trial
Asano T,
Jin Q,
Katagiri Y,
Kogame N,
Takahashi K,
Chang C,
Chichareon P,
Wang C,
Shi B,
Su X,
Fu G,
Wu Y,
Zhou X,
Yuan Z,
Wykrzykowska JJ,
Piek J,
Serruys P,
Onuma Y,
Chen Y
December 20, 2018 | 10.4244/EIJ-D-18-00461
Three-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and a durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction (TROFI II trial)
Katagiri Y,
Onuma Y,
Asano T,
Iñiguez A,
Jensen L,
Cequier A,
Hofma S,
Christiansen E,
Suttorp M,
Brugaletta S,
Räber L,
Sabaté M,
Windecker S,
Serruys P
December 7, 2018 | 10.4244/EIJ-D-18-00839
Optical coherence tomography substudy of a prospective multicentre randomised post-market trial to assess the safety and effectiveness of the Firehawk cobalt-chromium coronary stent (rapamycin target-eluting) system for the treatment of atherosclerotic lesions: TARGET All Comers
Baumbach A,
Lansky AJ,
Onuma Y,
Asano T,
Johnson TW,
Anderson R,
Kiemeneij F,
Zeng M,
van Royen N,
Slagboom T,
Vlachojannis GJ,
Serruys P,
Wijns W
November 20, 2018 | 10.4244/EIJ-D-18-00226
Relation between bioresorbable scaffold sizing using QCA-Dmax and long-term clinical outcomes in 1,232 patients from three study cohorts (ABSORB Cohort B, ABSORB EXTEND, and ABSORB II)
Katagiri Y,
Onuma Y,
Asano T,
Chichareon P,
Collet C,
Miyazaki Y,
Piek J,
Wykrzykowska JJ,
Abizaid A,
Ormiston J,
Chevalier B,
Serruys P
October 12, 2018 | 10.4244/EIJ-D-18-00301
Reply to the letter to the editor “Stenosis severity indices cannot reflect lumen loss in stent trials”
September 20, 2018 | 10.4244/EIJ-D-17-01073R
Quality difference of neointima following the implantation of everolimus-eluting bioresorbable scaffolds and metallic stents in patients with ST-elevation myocardial infarction: quantitative assessments by light intensity, light attenuation, and backscatter on optical coherence tomography in the TROFI II trial
Sotomi Y,
Onuma Y,
Liu S,
Asano T,
Eggermont J,
Katagiri Y,
Cavalcante R,
de Winter R,
Wykrzykowska JJ,
Brugaletta S,
Räber L,
Sabaté M,
Windecker S,
Dijkstra J,
Serruys P
August 24, 2018 | 10.4244/EIJ-D-17-00884
Functional comparison between the BuMA Supreme biodegradable polymer sirolimus-eluting stent and a durable polymer zotarolimus-eluting coronary stent using quantitative flow ratio: PIONEER QFR substudy
Asano T,
Katagiri Y,
Collet C,
Tenekecioglu E,
Miyazaki Y,
Sotomi Y,
Amoroso G,
Aminian A,
Brugaletta S,
Vrolix M,
Hernández-Antolín R,
van de Harst P,
Iñiguez A,
Janssens L,
Smits PC,
Wykrzykowska JJ,
Ribeiro V,
Pereira H,
da Silva P,
Piek J,
Reiber J,
von Birgelen C,
Sabaté M,
Onuma Y,
Serruys P
August 3, 2018 | 10.4244/EIJ-D-17-00461
Latest news
AHEAD OF PRINT
Robotic-assisted CABG: clinical outcomes
FREE ARTICLE - Aleksander Dokollari et al
November 23, 2023
PCR London Valves 2023
November 16, 2023
NEW ISSUE
PCR London Valves special edition. State-of-the-art on TMVI; the timing of TMVI; direct wire pacing for TMVR; predicting patient-prosthesis mismatch following TAVI and more
November 17, 2023
AHEAD OF PRINT
Pathophysiological CAD patterns predict outcomes post-PCI
FREE ARTICLE - Nozomi Kotoku et al
November 14, 2023
AHEAD OF PRINT
Extra-mitral valve cardiac involvement in MR
FREE ARTICLE - Antonio Popolo Rubbio et al
November 9, 2023
AHEAD OF PRINT
Cardiac damage classification in each AS subtype
FREE ARTICLE - Masaaki Nakase et al
November 6, 2023
AHEAD OF PRINT
CAPTIS embolic protection during TAVR
FREE ARTICLE - Haim D. Danenberg et al
November 2, 2023